KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMY) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Bristol Myers Squibb (BMY) over the last 16 years, with Q3 2025 value amounting to 0.1%.

  • Bristol Myers Squibb's Return on Capital Employed rose 1600.0% to 0.1% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.1%, marking a year-over-year increase of 1600.0%. This contributed to the annual value of 0.32% for FY2024, which is 2900.0% down from last year.
  • According to the latest figures from Q3 2025, Bristol Myers Squibb's Return on Capital Employed is 0.1%, which was up 1600.0% from 0.11% recorded in Q2 2025.
  • Bristol Myers Squibb's Return on Capital Employed's 5-year high stood at 0.02% during Q1 2023, with a 5-year trough of 0.32% in Q4 2024.
  • Its 5-year average for Return on Capital Employed is 0.11%, with a median of 0.1% in 2025.
  • Per our database at Business Quant, Bristol Myers Squibb's Return on Capital Employed soared by 1600bps in 2021 and then tumbled by -2900bps in 2024.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Return on Capital Employed stood at 0.02% in 2021, then plummeted by -54bps to 0.03% in 2022, then rose by 1bps to 0.03% in 2023, then plummeted by -915bps to 0.32% in 2024, then skyrocketed by 70bps to 0.1% in 2025.
  • Its last three reported values are 0.1% in Q3 2025, 0.11% for Q2 2025, and 0.12% during Q1 2025.